CAPH2 forms part of the condensin II complex, which ensures mitotic chromosome architecture and prevents DNA damage. Key functions include:
Chromatin compaction during prophase
Resolution of sister chromatids
Telomere stability maintenance
Mutations in CAPH2 (e.g., R551P, R551S, S556F) disrupt condensin II function, leading to:
Increased chromosomal instability (CIN)
Telomere-associated DNA damage
The Bethyl A302-276A antibody exhibits significant off-target effects:
Co-precipitates SWI/SNF components (SMARCA4, SMARCC1) in immunoprecipitation-mass spectrometry (IP-MS)
Fails to distinguish NCAPH2 depletion in auxin-inducible degradation systems
Custom antibodies show superior specificity for condensin II studies
Cancer-associated CAPH2 mutations impair condensin II through:
| Mutation | Chromatin Binding | SMC4 Interaction | Cellular Consequences |
|---|---|---|---|
| R551P | ↓ 65% | ↓ 78% | Telomere bridges, ATR-dependent damage |
| R551S | ↓ 58% | ↓ 82% | Micronuclei formation, aneuploidy |
| S556F | ↓ 72% | ↓ 91% | Chromosomal breaks, mitotic catastrophe |
For reliable CAPH2 detection:
CAPH2 is a regulatory subunit of the condensin-II complex. This complex plays a crucial role in organizing and stabilizing chromosomes, contributing significantly to mitotic chromosome architecture. Evidence suggests condensin-II is involved in DNA damage repair and genome protection against genotoxic stressors, such as boron excess, zeocin, and aphidicolin.